The brief
Summary: The University of Kansas Health System hosts the Oncology and Cancer Center, a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, formed from the 2011 merger with Kansas City Cancer Center. The center emphasizes access to cutting-edge cancer care, clinical trials, and leadership in research. In 2022, it earned NCI Comprehensive status, highlighting clinical trials, scientific leadership, and closer access to new therapies for patients. The center provides inpatient oncology services across multiple units, including Hematology/Oncology ICU (16 beds), Hematological Malignancies Unit (16 beds), Med Acute Leukemia and Hematology Oncology Unit (34 beds), and Blood and Marrow Transplant (BMT) and Cellular Therapy Unit (34 beds). The inpatient units focus on complex chemotherapy, immunotherapy, supportive care, trial treatments, and palliative care, with an emphasis on collaborative, attending-led care and specialized nursing teams.
Applications are completed on the employer's website.
